ADC Therapeutics S.A.

NYSE:ADCT

Biotechnology

Healthcare
$1.37 -1.35%

-$0.02 today

Market cap
$192.71M
Beta
1.77
P/E (TTM)
-1.2
EPS (TTM)
-$0.89
52W Low $0.78High $4.98

Volume 1.17M

Average 1.68M

Price history

ADC Therapeutics S.A. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-65.75%

Period high

$4.88

Period low

$0.96

Latest

$1.37

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
S-3Nov 10, 2026Nov 9, 2026
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
8-KNov 4, 2026Nov 4, 2026
S-4Nov 3, 2026Nov 3, 2026
SC 13GOct 29, 2026Oct 29, 2026
8-KOct 13, 2026Oct 13, 2026
SC 13GAug 14, 2026Aug 14, 2026
S-8Aug 13, 2026Aug 13, 2026
8-KAug 13, 2026Aug 13, 2026
10-QAug 13, 2026Aug 13, 2026
SC 13GJul 27, 2026Jul 27, 2026
4Jul 2, 2026Jul 2, 2026
4Jul 2, 2026Jul 2, 2026

Competitors

Who does ADC Therapeutics S.A. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ADCT's filings, answered from its disclosures.

What is the latest ADCT filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does ADCT have?

Intrinsic Alpha currently shows 20 recent filings for ADCT.